★★★★★Verified
“Gamma knife for vestibular schwannoma at Tiantan. Single session, day-stay. Three-month MRI showed no growth and hearing preserved. The neurosurgeon spoke fluent English and reviewed my outside imaging in detail.”
神经内科 · 神经外科 · 2026
Neurology & Neurosurgery,
Tiantan 天坛 · Huashan.
Stroke and neurovascular intervention, epilepsy surgery, DBS for Parkinson’s and other movement disorders, and memory-disorder workup at China’s NHC-designated national neuroscience centre.
★★★★★
4.7(3 verified reviews)
Tiantan
National neurosurgery
NHC reference for neuroscience
NHC designation
Huashan
National neurology
NHC reference for neurology
NHC designation
DBS
Multi-platform
Medtronic, Boston Sci, domestic NMPA
NMPA registry
GV-971
China-only AD drug
Conditionally NMPA-approved
NMPA registry
Procedures & pathways
What this specialty
covers in China.
Acute stroke / thrombectomy
🔥 Trending
Cerebrovascular surgery
Epilepsy surgery
🔥 Trending
DBS for Parkinson’s / dystonia
🔥 Trending
Memory clinic / Alzheimer’s
Read pathway →
Multiple sclerosis MDT
Gamma knife radiosurgery
Carotid endarterectomy / stenting
Top centres
Reference and
Class A teaching hospitals.
Beijing · NHC
Beijing Tiantan Hospital 北京天坛医院
NHC National Neuroscience Center · China’s neurosurgery flagship · stroke + neurovascular depth
Class A teaching
Shanghai · NHC
Huashan Hospital, Fudan 华山医院神经内科
Class A · National neurology reference · large memory-disorder programme · biomarker depth
Class A teaching
Beijing · NHC
Xuanwu Hospital, Capital Medical University 宣武医院
Class A · National geriatric neurology and memory disorders · cognitive trial site
Class A teaching
Beijing
Peking Union Medical College Hospital 北京协和医院
Class A · diagnostic excellence · atypical neurology and dementia phenotyping
Class A teaching
Centre comparison
At a glance.
Indicative starting price for this specialty: $3,500–35,000 all-in international-patient package, depending on procedure complexity and centre.
| Hospital | City | Tier | NHC | JCI | Strength |
|---|---|---|---|---|---|
| Beijing Tiantan Hospital 北京天坛医院 | Beijing | Class A teaching | ✓ | — | NHC National Neuroscience Center · China’s neurosurgery flagship · stroke + neurovascular depth |
| Huashan Hospital, Fudan 华山医院神经内科 | Shanghai | Class A teaching | ✓ | — | Class A · National neurology reference · large memory-disorder programme · biomarker depth |
| Xuanwu Hospital, Capital Medical University 宣武医院 | Beijing | Class A teaching | ✓ | — | Class A · National geriatric neurology and memory disorders · cognitive trial site |
| Peking Union Medical College Hospital 北京协和医院 | Beijing | Class A teaching | — | — | Class A · diagnostic excellence · atypical neurology and dementia phenotyping |
NHC = National Health Commission designation as National Clinical Research Centre / National Medical Centre / National Clinical Key Specialty. JCI = Joint Commission International accreditation. Class A teaching = 三级甲等, China’s top hospital tier.
Patient reviews
What patients say about neurology & neurosurgery in China.
★★★★★Verified
“Oligomannate (GV-971) for early-stage Alzheimer’s — only approved in China. Diagnosis confirmed at Xuanwu Memory Clinic with full PET-amyloid imaging. Six months in, MMSE has held steady and family reports clearer mornings.”
★★★★Verified
“DBS for Parkinson’s at Tiantan. Programming sessions over 10 days were demanding but very precise. Outcome at month 6 is excellent — UPDRS-III off-medication down 65%. Wished aftercare emails were faster.”
FAQ
Neurology & Neurosurgery in China — answered.
- Why China for neurology?
- Three reasons: (1) Tiantan Hospital is China’s NHC-designated National Neuroscience Center with world-leading neurosurgical volume; Huashan and Xuanwu are NHC neurology references for memory disorders and movement disorders; (2) DBS access is multi-platform (Medtronic, Boston Scientific, Abbott, plus several domestic NMPA-approved leads at lower cost); (3) memory clinic depth, including the China-only conditionally-approved oligomannate (GV-971) for mild-to-moderate Alzheimer’s — and full anti-amyloid mAb access (lecanemab, donanemab) for biomarker-positive early disease.
- DBS for Parkinson’s — pathway?
- Standard pathway: pre-arrival case review (motor scoring, levodopa-response test, prior imaging); on-arrival 5–7 day workup including movement-disorder consult, cognitive screen, MRI, dopamine-system PET if indicated; surgical planning and DBS implantation (typically 1–2 stage); programming and titration over 7–10 days; structured discharge with implant card, programmer settings and bilingual handover. All-in DBS package $25,000–35,000 vs $80,000–150,000 US private-payer.
Want a written centre-match shortlist
in 48 hours?
Tell us the clinical question and your travel window. We return two written centre-match shortlists for neurology & neurosurgery — including subspecialty fit, English-workflow status, and starting prices.